Share

October 06, 2015; 85 (14) Clinical/Scientific NotesOpen Access

Electrocortical therapy for motion sickness

Qadeer Arshad, Niccolo Cerchiai, Usman Goga, Yuliya Nigmatullina, R. Ed Roberts, Augusto P. Casani, John F. Golding, Michael A. Gresty, Adolfo M. Bronstein
First published September 4, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001989
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3240

Share

Article Information

vol. 85 no. 14 1257-1259
DOI: 
https://doi.org/10.1212/WNL.0000000000001989
PubMed: 
26341870
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 24, 2014
  • Accepted in final form April 14, 2015
  • First Published September 4, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Disclosures

    1. Qadeer Arshad, PhD*,
    2. Niccolo Cerchiai, MD*,
    3. Usman Goga, BSc,
    4. Yuliya Nigmatullina, PhD,
    5. R. Ed Roberts, PhD,
    6. Augusto P. Casani, MD,
    7. John F. Golding, PhD,
    8. Michael A. Gresty, PhD and
    9. Adolfo M. Bronstein, MD, PhD
  1. Qadeer Arshad, PhD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Niccolo Cerchiai, MD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Usman Goga, BSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Yuliya Nigmatullina, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. R. Ed Roberts, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Augusto P. Casani, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. John F. Golding, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Michael A. Gresty, PhD and
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Adolfo M. Bronstein, MD, PhD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Clinical Disorders of Balance, Posture and Gait (Edward Arnold 2004) and Dizziness: a practical approach to diagnosis and management (Cambridge University Press 2007).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Funding received from Imperial College London throughout the study period and ongoing.

    Research Support, Foundations and Societies:

    1. Funding received from UK Medical Research Council throughout the study period and ongoing.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  1. Correspondence to Dr. Bronstein: a.bronstein{at}imperial.ac.uk
View Full Text

Article usage

Article usage: September 2015 to December 2022

AbstractFullPdfSource
Sep 20152416181175Highwire
Oct 2015689143273Highwire
Oct 2015053pmc
Nov 201513410113Highwire
Nov 201503111pmc
Dec 20151292763Highwire
Dec 201503111pmc
Jan 20161122755Highwire
Jan 20160176pmc
Feb 2016931738Highwire
Feb 201603630pmc
Mar 20161281559Highwire
Mar 20160198pmc
Apr 2016912546Highwire
Apr 20160134pmc
May 2016971846Highwire
May 20160143pmc
Jun 20161021629Highwire
Jun 20160103pmc
Jul 201698832Highwire
Jul 20160125pmc
Aug 20161131137Highwire
Aug 20160218pmc
Sep 2016104736Highwire
Sep 20160207pmc
Oct 2016107331Highwire
Oct 201601810pmc
Nov 20161071435Highwire
Nov 20160128pmc
Dec 2016110712Highwire
Dec 201601510pmc
Jan 2017941215Highwire
Jan 20170224pmc
Feb 201787720Highwire
Feb 20170199pmc
Mar 201785220Highwire
Mar 2017091pmc
Apr 201769621Highwire
Apr 201752124pmc
May 2017781010Highwire
May 201731818pmc
Jun 201743818Highwire
Jun 201741212pmc
Jul 20173688Highwire
Jul 201741212pmc
Aug 201766831Highwire
Aug 201762123pmc
Sep 201741212Highwire
Sep 201761014pmc
Oct 201742811Highwire
Oct 201741312pmc
Nov 201751715Highwire
Nov 2017398pmc
Dec 2017401410Highwire
Jan 2018501624Highwire
Feb 2018321423Highwire
Mar 201835105Highwire
Apr 201830911Highwire
Apr 201831212pmc
May 2018301511Highwire
Jun 2018381215Highwire
Jun 201801415pmc
Jul 201827179Highwire
Aug 2018301012Highwire
Aug 2018178pmc
Sep 20183398Highwire
Oct 201841178Highwire
Nov 2018522417Highwire
Dec 2018482214Highwire
Jan 2019282311Highwire
Feb 201914377Highwire
Mar 2019119710Highwire
Apr 20192914019Highwire
May 2019131109Highwire
Jun 201921774Highwire
Jul 2019141469Highwire
Aug 2019112277Highwire
Sep 2019102255Highwire
Oct 2019172558Highwire
Nov 2019121648Highwire
Dec 201971149Highwire
Jan 202011209Highwire
Feb 20209298Highwire
Mar 20206153Highwire
Apr 20203196Highwire
May 20205228Highwire
Jun 20204219Highwire
Jul 202031911Highwire
Aug 20208125Highwire
Sep 202012246Highwire
Oct 2020334819Highwire
Nov 202084024Highwire
Dec 20206497Highwire
Jan 202132811Highwire
Feb 2021898Highwire
Mar 202183710Highwire
Apr 20215548Highwire
May 202173512Highwire
Jun 202183011Highwire
Jul 2021132214Highwire
Aug 2021123019Highwire
Sep 202172612Highwire
Oct 2021162437Highwire
Nov 202192224Highwire
Dec 202120309Highwire
Jan 202243011Highwire
Feb 20228258Highwire
Mar 2022102114Highwire
Apr 20228237Highwire
May 2022163218Highwire
Jun 20224246Highwire
Jul 20221265Highwire
Aug 20222165Highwire
Sep 202222914Highwire
Oct 202291511Highwire
Nov 202243212Highwire
Dec 20225246Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me